Table 2.
The 41 Probe Sets Demonstrating Concordant Up-regulation or Down-regulation in Both Comparisons between WT-FT and B1-FTocc or B1-CA.
| Affymetrix Probe Set | Gene Name | Gene Symbol | WT-FT vs B1-FTocc | WT-FT vs B1-CA | ||
| Fold | P | Fold | P | |||
| Downregulated | ||||||
| 230130_at | Transcribed locus | Unknown | 3.7 | .0020 | 3.4 | .0054 |
| 214078_at | Primary neuroblastoma cDNA | Unknown | 3.6 | .0003 | 7.4 | .0001 |
| 201843_s_at | EGF-containing fibulin-like extracellular matrix protein 1 | EFEMP1 | 3.4 | .0015 | 12.4 | .0001 |
| 205568_at | Aquaporin 9 | AQP9 | 2.7 | .0021 | 3.4 | .0020 |
| 214235_at | Cytochrome P450, family 3, subfamily A | CYP3A5 | 2.7 | .0048 | 5.2 | .0023 |
| 226228_at | Aquaporin 4 | AQP4 | 2.6 | .0081 | 7.7 | .0003 |
| 213182_x_at | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | CDKN1C | 2.5 | .0008 | 3.1 | .0014 |
| 203710_at | Inositol 1,4,5-triphosphate receptor, type 1 | ITPR1 | 2.4 | .0004 | 3.7 | .0002 |
| 214607_at | p21 (CDKN1A)-activated kinase 3 | PAK3 | 2.4 | .0070 | 5.8 | .0002 |
| 231183_s_at | Jagged 1 (Alagille syndrome) | JAG1 | 2.3 | .0002 | 1.9 | .0011 |
| 218656_s_at | Lipoma HMGIC fusion partner | LHFP | 2.3 | .0032 | 2.8 | .0083 |
| 218717_s_at | Leprecan-like 1 | LEPREL1 | 2.3 | .0034 | 2.9 | .0034 |
| 229480_at | MRNA; cDNA DKFZp686I18116 | Unknown | 2.1 | .0018 | 2.2 | .0002 |
| 209506_s_at | Nuclear receptor subfamily 2, group F, member 1 | NR2F1 | 2.1 | .0036 | 7.5 | .0000 |
| 231262_at | Transcribed locus | Unknown | 2.1 | .0035 | 3.0 | .0088 |
| 201497_x_at | Myosin, heavy chain 11, smooth muscle | MYH11 | 2.1 | .0068 | 15.5 | .0000 |
| 236277_at | Primary neuroblastoma cDNA | Unknown | 2.0 | .0094 | 3.5 | .0001 |
| 201885_s_at | Cytochrome b5 reductase 3 | CYB5R3 | 2.0 | .0004 | 1.8 | .0066 |
| 230233_at | Transcribed locus | Unknown | 2.0 | .0047 | 1.9 | .0073 |
| 1557866_at | Chromosome 9 open reading frame 117 | C9orf117 | 2.0 | .0013 | 6.0 | .0001 |
| 201162_at | Insulin-like growth factor binding protein 7 | IGFBP7 | 2.0 | .0088 | 6.1 | .0000 |
| 201427_s_at | Selenoprotein P, plasma, 1 | SEPP1 | 2.0 | .0004 | 2.3 | .0010 |
| 213451_x_at | Transcribed locus, sim to tenascin XB isoform 1 | TNXB | 1.9 | .0072 | 5.3 | .0002 |
| 218087_s_at | Sorbin and SH3 domain containing 1 | SORBS1 | 1.9 | .0082 | 2.1 | .0038 |
| 204235_s_at | GULP, engulfment adaptor PTB domain containing 1 | GULP1 | 1.9 | .0006 | 4.8 | .0000 |
| 218718_at | Platelet-derived growth factor C | PDGFC | 1.9 | .0007 | 1.8 | .0059 |
| 209575_at | Interleukin 10 receptor, beta | IL10RB | 1.9 | .0010 | 1.8 | .0016 |
| 209505_at | Nuclear receptor subfamily 2, group F, member 1 | NR2F1 | 1.8 | .0096 | 7.0 | .0000 |
| 37005_at | Neuroblastoma, suppression of tumorigenicity 1 | NBL1 | 1.8 | .0066 | 2.5 | .0017 |
| Upregulated | ||||||
| 225857_s_at | Hypothetical LOC388796 | LOC388796 | 2.4 | .0000 | 2.6 | .0000 |
| 238482_at | Kruppel-like factor 7 (ubiquitous) | KLF7 | 2.4 | .0020 | 2.2 | .0050 |
| 39966_at | Chondroitin sulfate proteoglycan 5 | CSPG5 | 2.1 | .0030 | 6.2 | .0000 |
| 203693_s_at | E2F transcription factor 3 | E2F3 | 2.1 | .0054 | 6.4 | .0000 |
| 1560622_at | CDNA FLJ20196 fis, clone COLF0944 | Unknown | 2.0 | .0038 | 2.2 | .0005 |
| 201577_at | Nonmetastatic cells 1, protein (NM23A) | NME1 | 1.9 | .0066 | 3.0 | .0002 |
| 65588_at | Hypothetical LOC388796 | LOC388796 | 1.9 | .0000 | 2.3 | .0001 |
| 224474_x_at | SMEK homolog 2, suppressor of mek1 | SMEK2 | 1.9 | .0087 | 2.0 | .0037 |
| 212020_s_at | Antigen identified by monoclonal antibody Ki-67 | MKI67 | 1.9 | .0056 | 3.5 | .0000 |
| 224623_at | Transcribed locus, similar THO complex 3 | THOC3 | 1.8 | .0003 | 3.2 | .0000 |
| 1560258_a_at | Homo sapiens, clone IMAGE:5590287, mRNA | Unknown | 1.8 | .0044 | 3.0 | .0000 |
| 216262_s_at | TGFB-induced factor homeobox 2 | TGIF2 | 1.8 | .0094 | 1.8 | .0033 |